• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲家族性胰腺癌中4q32 - 34位点的评估

Evaluation of the 4q32-34 locus in European familial pancreatic cancer.

作者信息

Earl Julie, Yan Li, Vitone Louis J, Risk Janet, Kemp Steve J, McFaul Chris, Neoptolemos John P, Greenhalf William, Kress Ralf, Sina-Frey Mercedes, Hahn Stephan A, Rieder Harald, Bartsch Detlef K

机构信息

Division of Surgery and Oncology, University of Liverpool, Liverpool, United Kingdom.

出版信息

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1948-55. doi: 10.1158/1055-9965.EPI-06-0376.

DOI:10.1158/1055-9965.EPI-06-0376
PMID:17035404
Abstract

BACKGROUND

Familial pancreatic cancer (FPC) describes a group of families where the inheritance of pancreatic cancer is consistent with an autosomal-dominant mode of inheritance. The 4q32-34 region has been previously identified as a potential locus for FPC in a large American family.

METHODS

The region was allelotyped in 231 individuals from 77 European families using nine microsatellite markers, and haplotyping was possible in 191 individuals from 41 families. Families were selected based on at least two affected first-degree relatives with no other cancer syndromes.

RESULTS

Linkage to most of the locus was excluded based on LOD scores less than -2.0. Eight families were excluded from linkage to 4q32-34 based on haplotypes not segregating with the disease compared with a predicted six to seven families. Two groups of families were identified, which seem to share common alleles within the minimal disease-associated region of 4q32-34, one group with an apparently earlier age of cancer death than the other pancreatic cancer families. Four genes were identified with potential tumor suppressor roles within the locus in regions that could not be excluded based on the LOD score. These were HMGB2, PPID, MORF4, and SPOCK3. DNA sequence analysis of exons of these genes in affected individuals and in pancreatic cancer cell lines did not reveal any mutations.

CONCLUSION

This locus is unlikely to harbor a FPC gene in the majority of our European families.

摘要

背景

家族性胰腺癌(FPC)指的是一组家族,其中胰腺癌的遗传符合常染色体显性遗传模式。先前在一个美大家族中,4q32 - 34区域已被确定为FPC的一个潜在位点。

方法

使用9个微卫星标记对来自77个欧洲家族的231名个体进行该区域的等位基因分型,对来自41个家族的191名个体进行单倍型分型。这些家族是基于至少两名受影响的一级亲属且无其他癌症综合征而选择的。

结果

基于小于 -2.0的对数优势分数(LOD),排除了与该位点大部分区域的连锁关系。与预测的6至7个家族相比,基于单倍型不与疾病分离,8个家族被排除与4q32 - 34的连锁关系。确定了两组家族,它们似乎在4q32 - 34最小疾病相关区域内共享共同等位基因,一组癌症死亡年龄明显早于其他胰腺癌家族。在基于LOD分数无法排除的区域内,该位点确定了4个具有潜在肿瘤抑制作用的基因。它们是HMGB2、PPID、MORF4和SPOCK3。对受影响个体和胰腺癌细胞系中这些基因的外显子进行DNA序列分析未发现任何突变。

结论

在我们大多数欧洲家族中,该位点不太可能含有FPC基因。

相似文献

1
Evaluation of the 4q32-34 locus in European familial pancreatic cancer.欧洲家族性胰腺癌中4q32 - 34位点的评估
Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1948-55. doi: 10.1158/1055-9965.EPI-06-0376.
2
Linkage analysis of chromosome 4 in families with familial pancreatic cancer.家族性胰腺癌家族中4号染色体的连锁分析。
Cancer Biol Ther. 2007 Mar;6(3):320-3. doi: 10.4161/cbt.6.3.3721. Epub 2007 Mar 15.
3
A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34.一个新的常染色体显性遗传性胰腺癌易感基因座定位于4号染色体的q32 - 34区域。
Am J Hum Genet. 2002 Apr;70(4):1044-8. doi: 10.1086/339692. Epub 2002 Feb 27.
4
Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.特拉华州家族性胰腺癌的全州回顾性研究以及胰腺癌家族中基因突变的频率。
Ann Surg Oncol. 2016 May;23(5):1729-35. doi: 10.1245/s10434-015-5026-x. Epub 2016 Jan 4.
5
Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.帕拉丁基因突变导致家族性胰腺癌,并提示一种新的癌症机制。
PLoS Med. 2006 Dec;3(12):e516. doi: 10.1371/journal.pmed.0030516.
6
A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.对家族性胰腺癌家族的候选基因进行全面分析,揭示了高频率的潜在致病性种系变异。
EBioMedicine. 2020 Mar;53:102675. doi: 10.1016/j.ebiom.2020.102675. Epub 2020 Feb 27.
7
CDKN2A germline mutations in familial pancreatic cancer.家族性胰腺癌中的CDKN2A种系突变
Ann Surg. 2002 Dec;236(6):730-7. doi: 10.1097/00000658-200212000-00005.
8
Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.德国家族性胰腺癌家族中 BRCA2 和 CDKN2a 突变的流行率。
Fam Cancer. 2010 Sep;9(3):335-43. doi: 10.1007/s10689-010-9329-6.
9
Evidence of susceptibility loci on 4q32 and 16p12 for bipolar disorder.双相情感障碍4q32和16p12上易感基因座的证据。
Hum Mol Genet. 2003 Aug 1;12(15):1907-15. doi: 10.1093/hmg/ddg199.
10
A new locus for autosomal recessive RP (RP29) mapping to chromosome 4q32-q34 in a Pakistani family.在一个巴基斯坦家族中,常染色体隐性视网膜色素变性(RP29)的一个新基因座定位于4号染色体q32-q34区域。
Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1436-8.

引用本文的文献

1
PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer.一个欧洲家族的 PALLD 突变导致家族性胰腺癌的基质倾向性。
JCI Insight. 2021 Mar 25;6(8):141532. doi: 10.1172/jci.insight.141532.
2
Germline mutations in pancreatic cancer and potential new therapeutic options.胰腺癌中的种系突变及潜在的新治疗选择。
Oncotarget. 2017 Apr 20;8(42):73240-73257. doi: 10.18632/oncotarget.17291. eCollection 2017 Sep 22.
3
Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
胰腺癌早期检测:利用临床和代谢组学参数扩大高危人群范围。
World J Gastroenterol. 2015 Feb 14;21(6):1707-17. doi: 10.3748/wjg.v21.i6.1707.
4
The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma.细胞核中高迁移率族蛋白B1(HMGB1)呈阳性表达而高迁移率族蛋白B2(HMGB2)呈阴性表达的这种组合,可能与胰腺导管腺癌患者生存期缩短有关。
Tumour Biol. 2014 Oct;35(10):10555-69. doi: 10.1007/s13277-014-2328-8. Epub 2014 Jul 26.
5
Transcriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genes.正常和神经胶质瘤来源的神经前体细胞之间的转录差异鉴定出一组核心失调基因。
Cell Rep. 2013 Jun 27;3(6):2127-41. doi: 10.1016/j.celrep.2013.04.035. Epub 2013 May 30.
6
Innovations in proteomic profiling of cancers: alternative splice variants as a new class of cancer biomarker candidates and bridging of proteomics with structural biology.癌症蛋白质组谱分析的创新:选择性剪接变体作为一类新的癌症生物标志物候选物,以及将蛋白质组学与结构生物学联系起来。
J Proteomics. 2013 Sep 2;90:28-37. doi: 10.1016/j.jprot.2013.04.007. Epub 2013 Apr 17.
7
Familial pancreatic cancer--current knowledge.家族性胰腺癌——现有知识。
Nat Rev Gastroenterol Hepatol. 2012 Aug;9(8):445-53. doi: 10.1038/nrgastro.2012.111. Epub 2012 Jun 5.
8
Current knowledge on pancreatic cancer.当前对胰腺癌的认识。
Front Oncol. 2012 Jan 31;2:6. doi: 10.3389/fonc.2012.00006. eCollection 2012.
9
Pancreatic cancer screening.胰腺癌筛查。
Gastroenterol Clin North Am. 2012 Mar;41(1):143-57. doi: 10.1016/j.gtc.2011.12.001. Epub 2012 Jan 5.
10
Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.家族性胰腺癌与遗传性综合征:高危个体的筛查策略。
J Gastroenterol. 2011 Nov;46(11):1249-59. doi: 10.1007/s00535-011-0457-z. Epub 2011 Aug 17.